Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Primary Care/Hospitalist

RSS  

Articles

  • MedPAC discusses, but doesn't equalize pay rates

    In recent discussions, the Medicare Payment Advisory Commission (MedPAC), for the first time, proposed equalization between hospital outpatient departments (HOPDs) and ambulatory surgery centers (ASCs) for certain procedures, according to the ASC Association.
  • ACOG: Robotic surgery is not the best

    While many women are hearing about the claimed advantages of robotic surgery for hysterectomy, thanks to widespread marketing and advertising, robotic surgery is not the best minimally invasive approach for hysterectomy, according to James T. Breeden, MD, president of the American College of Obstetricians and Gynecologists (ACOG).
  • Top 10 technology issues for healthcare in 2013

    A new Watch List from ECRI Institute, an independent nonprofit that researches approaches to improving patient care, provides a roadmap to 10 technology issues that healthcare leaders should have on their radar in 2013 and beyond.
  • 'High reliability' hospital obsessed with safety

    When you walk on an airplane, you expect layers of precautions to prevent any error that could lead to failure and injury. You demand the same or even greater care from the nearby nuclear power plant. And now, you can expect that serious attention to safety from a growing number of healthcare providers.
  • 5 steps to compliance with OSHA regulations

    What can you, as a manager, do to help ensure members of your staff are complying with sharps safety regulations?
  • Pharmacology Update: Canagliflozin Tablets (Invokana™)

    The first in a new class of drugs has been approved by the FDA for the treatment of diabetes mellitus. This new class of drugs decreases the renal threshold for glucose excretion by inhibiting the sodium-glucose co-transporter 2 (SGLT2), thus increasing renal clearance of glucose. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation and marketed by Janssen Pharmaceuticals as Invokana.
  • Clinical Briefs By Louis Kuritzky, MD

    Omalizumab for Asthma in Real Life; Tenofovir: New Hope for Hepatitis B Patients; H. pylori: Frequency of Recurrence After Successful Eradication
  • ‘Off-target’ Effects? The Role of Statins in Cancer Biology

    Statin use among cancer patients with diverse malignancies is associated with reduced cancer-related mortality. The mechanism is plausible since statins inhibit cholesterol synthesis, which reduces the pool of compounds necessary in cellular proliferation and maintenance of critical cellular functions, such as membrane integrity, signaling, protein synthesis, and cell cycle progression. Prospective clinical trials are warranted.
  • Doxycycline May Protect Against Clostridium Difficile Infection

    This retrospective study of hospitalized patients receiving ceftriaxone found that additional treatment with doxycycline compared to other antibiotics was associated with a lower risk of Clostridium difficile infection.
  • Does MRI Have Your Patient’s Back?

    MRI scan was unable to discriminate between patients with favorable outcome and those with an unfavorable outcome when conducted at 1-year follow-up in patients who were treated for sciatica and disk herniation.